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A key question for understanding the mechanism of autoimmune disease is how hazardous self-reactive T cells are produced by the thymus, become activated in the periphery, and diff erentiate to eff ector T cells that destroy the target organ, or how genetic and environmental factors contribute to this process. Autoimmune disease due to a defect of a single gene is instrumental in addressing these questions, especially when the disease is clinically and immunologically similar to common autoimmune diseases that are supposed to be multifactorial (1) .
The SKG strain of mice, a mutant on the BALB/c background, spontaneously develops T cell-mediated autoimmune arthritis, which clinically and immunologically resembles rheumatoid arthritis (RA) in humans (2, 3) . The strain harbors a recessive mutation of the gene encoding an SH2 domain of ζ-associated protein 70 (ZAP-70), a key signaling molecule in T cells (4) . Impaired signal transduction through SKG ZAP-70 results in thymic positive selection and failure in negative selection of highly self-reactive T cells that include potentially arthritogenic CD4 + T cells (2) . SKG mice spontaneously develop severe arthritis in a conventional environment, whereas they fail to develop the disease in microbially clean environments, for example, under a specifi c pathogen-free (SPF) condition (5) . Yet arthritis can be elicited in an SPF environment through antigen-nonspecifi c activation of innate immunity, for example, by injection of zymosan, a crude fungal extract containing β-glucans, or purifi ed β-glucans such as laminarin (5) . The disease can also be triggered by provoking homeostatic proliferation of self-reactive T cells (5) . The strain is therefore a suitable model for elucidating how self-reactive T cells develop and diff erentiate to arthritogenic eff ector T cells, and how autoimmune arthritis can be triggered by environmental insults in the presence of genetic predisposition.
In this report, we show that autoimmune arthritis in SKG mice is highly dependent on the development of CD4 + T cells secreting IL-17, a proinfl ammatory cytokine capable of recruiting and activating neutrophils and other infl ammatory cells (6) . We have analyzed how self-reactive CD4 + T cells produced by the thymus diff erentiate to arthritogenic Th17 cells through internally forming a particular cytokine milieu by interacting with APCs, and how they become activated to cause autoimmune arthritis.
RESULTS AND DISCUSSION Spontaneous development of arthritogenic Th17 cells in SKG mice and its augmentation by zymosan or -glucan administration
In vitro PMA/ionomycin treatment for 5 h, which activates a signal transduction step down-stream of ZAP-70 and therefore equally activates SKG and BALB/c T cells, revealed that a signifi cant fraction of LN CD4 + T cells from nonarthritic SKG mice in an SPF environment were producing IL-17A (hereafter IL-17), whereas SKG or BALB/c CD4-SP thymocytes or BALB/c CD4 + T cells were not ( Fig. 1 A and Fig.  S1 , which is available at http://www.jem.org/cgi/content/ full/jem.20062259/DC1). Such IL-17-producing SKG CD4 + T cells also produced at a single cell level TNF-α and IL-2, but not IFN-γ, IL-4, or IL-10, a profi le distinct from Th1 or Th2 cells and similar to that of Th17 cells (Fig. 1 A; references 7-9). CD4 + T cells freshly prepared from nonarthritic SKG mice also actively transcribed IL-17 and IL-23R mRNA (Fig. 1 B) . In arthritic SKG mice raised in a conventional environment, arthritic joints actively transcribed IL-17 mRNA, whereas nonarthritic ones did not (Fig. 1 C) . Correspondingly, CD4 + T cells producing IL-17 and not IFN-γ infi ltrated into the arthritic joints as revealed by intracellular cytokine staining of CD4 + T cells dispersed from the infl amed synovial tissue (Fig. 1 D; reference 5 ). Both IL-17-intact (IL-17 +/+ ) and -defi cient (IL-17 −/− ) SKG mice, prepared by genetic backcrossing from IL-17 −/− BALB/c mice (10), did not develop arthritis under our SPF conditions, although the former harbored IL-17-producing CD4 + T cells (Fig.  1 A) . When CD4 + T cell suspensions prepared from each strain were transferred to RAG2 −/− BALB/c mice, however, all the recipients of IL-17 +/+ CD4 + T cells developed arthritis with high arthritis scores within 3 mo, whereas none of those transferred with IL-17 −/− CD4 + T cells showed joint swelling (Fig. 1 E) . The former exhibited histologically severe synovitis and destruction of cartilage and bone (Fig. 1 F) . Furthermore, injection of zymosan or laminarin, which can trigger arthritis in SPF SKG mice (5), increased three-to fourfold the number of IL-17 + cells in SKG, but not in BALB/c mice (Fig. 1 G) . Thus, naive CD4 + T cells in SKG mice are spontaneously activated and diff erentiate to Th17 cells, which are indispensable for the development of this autoimmune disease. Such potentially arthritogenic Th17 cells appear to persist in the periphery and begin mediating arthritis 
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when stimulated, for example, by their transfer to a T celldefi cient environment and resulting homeostatic proliferation (see also below), or by exposure to microbial products, such as fungal or bacterial β-glucans, which further facilitate expansion/diff erentiation of Th17 cells, presumably by stimulating APCs (5). In addition, complete inhibition of disease development by the defi ciency of IL-17 alone indicates that IL-17F, another IL-17 family member secreted by CD4 + T cells and having a similar function (6) , is dispensable for the disease. (Fig. 2 B) . Divided cells constituted 50% of SKG CD4 + T cells within 3 wk compared with 20% of BALB/c CD4 + T cells (Fig. 2 C) . Thymectomy in adults did not aff ect the proliferation, indicating that the proliferating T cells are not recent thymic emigrants, but peripheral T cells (Fig. 2 C) . When heat-stable antigen-negative (HSA − ) CD4-SP mature thymocytes or splenic CD4 + T cells labeled by CFSE were transferred to RAG2 −/− mice, transferred SKG CD4 + T cells or thymocytes gave rise to higher percentages of CFSE-diluted (i.e., proliferating) cells, in particular highly proliferating CFSE low cells, than their BALB/c counterparts (Fig. 2 D) . Notably, BALB/c CD4 + T cells, which scarcely produced IL-17 before transfer (Fig. 1 A) , also diff erentiated spontaneously to Th17 cells to a similar extent as SKG CD4 + T cells (Fig. 2 E) . The diff erentiation required cell division: BALB/c CD4 + T cells produced IL-17 or IFN-γ only after several cell divisions.
Collectively, these results indicate that SKG thymus produces highly self-reactive T cells, which are constantly activated in the periphery, proliferate, and diff erentiate to Th17 cells (Fig. 1 A) . Both SKG and BALB/c T cells can equally diff erentiate to Th17 as well as Th1 cells after homeostatic proliferation; however, BALB/c T cells fail to produce arthritis in this setting, presumably because of their lack or insuffi ciency of relevant arthritogenic self-reactivity.
In vitro self-reactivity of SKG CD4 + T cells and their stimulation of APCs to secrete cytokines Supporting the in vivo high proliferative activity of SKG T cells, SKG CD4-SP mature thymocytes and CD4 + T cells exhibited vigorous in vitro proliferative responses to autologous APCs, and the responses were completely inhibited by adding anti-class II MHC mAb to the culture (Fig. 3 A) . They produced large amounts of IL-6 and TNF-α in this autologous MLR (AMLR), whereas only peripheral CD4 + T cells produced a detectable amount of IL-17 (Fig. 3 B) . Use of cytokine-defi cient BALB/c APCs or SKG CD4 + T cells in various combinations revealed that IL-6 was predominantly derived from APCs, TNF-α from both SKG CD4 + T cells and BALB/c APCs, and IL-17 solely from SKG CD4 + T cells (Fig. 3 C) . Moreover, blockade of CD40L substantially reduced cell proliferation and production of IL-6, TNF-α, and IL-17. OX40L blockade exerted similar eff ects, although to lesser extents (Fig. 3 D) . Collectively, SKG CD4 + thymocytes and T cells strongly respond to class II MHC/self-peptide complexes expressed by autologous APCs, and reciprocally stimulate APCs to secrete IL-6 and TNF-α. In addition, CD40-CD40L and to a lesser extent OX40-OX40L interactions contribute to this T cell-APC interaction and, consequently, to the formation of IL-17 by T cells, IL-6 by APCs, and TNF-α by both.
Critical role of IL-6 for the development of arthritogenic Th17 cells in SKG mice
We then examined with cytokine-defi cient SKG mice how a cytokine milieu aff ects in vivo spontaneous development of Th17 cells in SKG mice. IL-6-defi cient SKG mice were completely devoid of IL-17 + CD4 + T cells, whereas TNF-α-, IL-1-, or IFN-γ-defi cient SKG mice harbored equivalent numbers of IL-17 + CD4 + T cells as cytokine-intact SKG mice (Fig. 4 A) . When IL-6 −/− SKG or BALB/c CD4 + T cells devoid of Th17 cells were transferred to IL-6 +/+ RAG2 −/− mice, they gave rise to Th17 cells within a week after homeostatic proliferation (Fig. 4 B) . This in vivo Th17 diff erentiation did not happen in the transfer of SKG or BALB/c IL-6 −/− T cells to IL-6 −/− RAG2 −/− mice and occurred to a small degree when either the T cell donors or the recipients were IL-6 defi cient. Of note in these cell transfers is that the degree of Th17 development from SKG CD4 + T cells was well correlated with the incidence and severity of arthritides in the recipients (Fig. 4 C) .
Collectively, IL-6 produced by either T cells or non-T cells is indispensable for in vivo development and/or expansion of Th17 cells and consequently the occurrence of auto immune arthritis. IL-6 produced by either cell source is synergistic in promoting this T cell diff erentiation and autoimmune development. Although IL-23 is capable of amplifying and sustaining Th17 cells (11) , it is unable to replace the function of IL-6 to induce Th17 cells. In addition, not only SKG CD4 + T cells but also CD4 + T cells in normal BALB/c mice are similarly dependent on IL-6 in this setting of Th17 diff erentiation.
Spontaneous development of arthritis in IFN--defi cient SKG mice due to enhanced Th17 differentiation
Notably, IFN-γ-defi cient SKG mice spontaneously developed histologically severe arthritides even under SPF conditions (Fig. 5, A and B) . After homeostatic proliferation in 
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RAG2 −/− mice, CD4 + T cells from IFN-γ −/− SKG mice diff erentiated more effi ciently to Th17 cells than IFN-γ +/+ SKG CD4 + T cells, suggesting that IFN-γ may suppress the diff erentiation/expansion of Th17 cells (Fig. 5 C) . To examine the relationship between IL-6 and IFN-γ in this Th17 diff erentiation, we blocked IL-6R by administering anti-IL-6R mAb to RAG2 −/− mice transferred with CD4 + T cells from wild-type, IFN-γ −/− , or IL-17 −/− mice (Fig. 5 C) . The blockade inhibited the diff erentiation/expansion of both normal and IFN-γ −/− CD4 + T cells to Th17 cells, indicating that IL-6 can directly promote Th17 diff erentiation, and not via the reduction of IFN-γ. In addition, IL-17 −/− CD4 + T cells more effi ciently diff erentiated/expanded to IFN-γ-producing cells than wild-type CD4 + T cells, and IL-6R blockade facilitated this diff erentiation/expansion of both wild-type and IL-17 −/− CD4 + T cells.
Thus, these fi ndings, together with effi cient development of IFN-γ-producing cells under IL-6 defi ciency (Fig. 4 B) and the known capacity of IL-6 to directly inhibit Th1 cell diff erentiation (12) , indicate that IL-6 and IL-17 suppress Th1 diff erentiation and IFN-γ production, and, reciprocally, IFN-γ suppresses Th17 diff erentiation. This in vivo crossregulation between IL-17/IL-6 and IFN-γ plays a critical role in the maintenance of immunological self-tolerance, as IFN-γ defi ciency can break self-tolerance in SPF SKG mice by facilitating the diff erentiation/expansion of arthritogenic Th17 cells.
In vivo contribution of TGF-and natural regulatory T (T reg) cells to the development of Th17 cells
There is recent in vitro evidence that IL-6 and TGF-β together promote the diff erentiation of naive CD4 + T cells to Th17 cells and IFN-γ inhibits it (8, 9, (13) (14) (15) . In our in vivo induction of Th17 cells from BALB/c or SKG CD4 + T cells via homeostatic proliferation, i.v. administration of neutralizing anti-TGF-β mAb at in vivo-saturating doses reduced the number of IL-17 + cells to a half of control mice without reduction of IFN-γ + cells (Fig. 5 D and Fig. S2 , which is available at http://www.jem.org/cgi/content/full/ jem.20062259/DC1). CD25 + CD4 + natural T reg cells were suggested as a possible source of TGF-β (13). Th17 cells, however, equally developed from CD25 + cell-depleted or nondepleted BALB/c T cells after homeostatic proliferation (Fig. 5 E; reference 16) . Furthermore, T reg cell depletion exacerbated SKG arthritis, whereas inoculation of natural T reg cells from normal BALB/c mice suppressed disease development (unpublished data). Thus, TGF-β physiologically produced by various tissues may promote in vivo Th17 differentiation in the presence of IL-6. How natural T reg cells are involved in this process remains to be determined.
The SKG thymus produces self-reactive T cells with a variety of antigen specifi cities as illustrated by polyclonal activation of self-reactive thymocytes and T cells in AMLR. Some self-reactive T cells may recognize joint self-antigens as indicated by their helper function for the development of IgG autoantibodies against type II collagen and other constituents of the joint (2) . Others may stimulate APCs to secrete cytokines, especially IL-6, and, together with T cell-derived IL-6, form a cytokine milieu for the preferential diff erentiation of joint-specifi c self-reactive T cells to Th17 cells. Other cytokines, including IFN-γ, TGF-β, TNF-α, IL-1, and IL-23, may also positively or negatively contribute to forming the cytokine milieu for Th17 development (3, 13, 17, 18) . With this generation and persistence of potentially arthritogenic autoimmune Th17 cells in apparently nonarthritic animals, various extrinsic or intrinsic stimuli (e.g., exposure to physical, chemical, or biological agents that activate APCs, cause T lymphocytopenia, or alter cytokine milieu) may precipitate arthritis by further facilitating expansion/diff erentiation of arthritogenic Th17 cells.
The etiology of RA is largely obscure at present (19) . Yet a genetically determined T cell anomaly might play a role in its pathogenesis in some RA patients, as suggested by recent fi ndings that genetic polymorphism of a signaling molecule at a TCR proximal step signifi cantly contributes to the susceptibility to RA (20, 21) . The polymorphism might contribute to thymic generation of potentially arthritogenic self-reactive T cells and their diff erentiation to arthritogenic Th17 cells, as shown here with a mouse model of RA.
MATERIALS AND METHODS
Mice. BALB/c and BALB/c IFN-γ −/− mice were purchased from Japan Clea and The Jackson Laboratory, respectively. BALB/c IL-17 −/− mice were described previously (10) . IL-1 −/− , IL-6 −/− , or TNF-α −/− mice were backcrossed to BALB/c more than eight times and crossed to SKG mice to make cytokine-defi cient SKG mice (3). RAG2 −/− BALB/c mice were crossed to IL-6 −/− mice to generate IL-6 −/− RAG2 −/− BALB/c mice. These mice were maintained in our animal facility and treated in accordance with the guidelines of Kyoto University. Intracellular cytokine staining. LN or spleen cells were stimulated with 20 ng/ml PMA and 1 μM ionomycin in the presence of GolgiStop (BD Biosciences) for 5 h, and then stained with anti-CD4 or anti-TCR-αβ and fi xed and permeabilized using BD Cytofi x/Cytoperm (BD Biosciences), followed by anti-IL-17 and anti-IFN-γ, TNF-α, IL-2, IL-4, or IL-10 staining.
In vivo BrdU labeling. Mice were i.p. injected with 1.0 mg BrdU (SigmaAldrich) every 12 h twice and given 0.8 mg/ml BrdU in drinking water until cytofl uorometric analysis.
Lymphocyte labeling with CFSE. HSA − CD4-SP thymocytes or CD4 + T cells were labeled with 3 μM CFSE (Dojindo).
AMLR. 2 × 10 4 HSA − CD4-SP thymocytes or CD4 + T cells were cultured with 10 5 BALB/c splenic APCs, which were prepared by depleting Thy1.2 + cells by MACS (Miltenyi Biotec) in a 96-well round-bottom plate in complete RPMI medium. [ 3 H]thymidine (1 μCi/well; Du Pont/New England Nuclear) was added during the last 12 h of culture.
Measurement of cytokines. IL-6 and TNF-α were measured by Cytometric Bead Array (BD Biosciences), with the detection limits of 2 pg/ml for IL-6 and 7 pg/ml for TNF-α. IL-17 was measured by ELISA (R&D Systems), with the detection limit of 11 pg/ml. Statistical analysis. Student's t test was used for statistical analyses. All p-values ≤0.05 were considered signifi cant. 
